ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.37 HKD | +2.74% |
|
+9.77% | -20.52% |
| May. 28 | Hong Kong Stocks Stayed Flat Despite Shanghai’s Property Cuts, Beijing’s Huge Investment Plan | MT |
| May. 28 | Alibaba Health Shares Rise on Earnings Beat | DJ |
| Sales 2024 | 27.03B 3.73B 29.17B | Sales 2025 * | 31.26B 4.31B 33.74B | Capitalization | 48.85B 6.74B 52.73B |
|---|---|---|---|---|---|
| Net income 2024 | 883M 122M 953M | Net income 2025 * | 1.61B 222M 1.74B | EV / Sales 2024 | 1.75 x |
| Net cash position 2024 * | 10.91B 1.51B 11.78B | Net cash position 2025 * | 11.1B 1.53B 11.98B | EV / Sales 2025 * | 1.21 x |
| P/E ratio 2024 |
46.8
x | P/E ratio 2025 * |
28.7
x | Employees | 1,435 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 37.22% |
More Fundamentals
* Assessed data
More news
More recommendations
More press releases
More news
| 1 day | +2.74% | ||
| 1 week | +9.77% | ||
| Current month | +2.74% | ||
| 1 month | +2.74% | ||
| 3 months | -4.26% | ||
| 6 months | -22.17% | ||
| Current year | -20.52% |
1 week
3.20
3.65
1 month
2.903.65
Current year
2.594.30
1 year
2.595.82
3 years
2.5919.68
5 years
2.5930.15
10 years
2.5930.15
| Managers | Title | Age | Since |
|---|---|---|---|
Di Fan Shen
CEO | Chief Executive Officer | 46 | - |
Yan Wu Tu
DFI | Director of Finance/CFO | 46 | 19-08-31 |
Shun Yan Zhu
CHM | Chairman | 53 | 20-03-15 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Yi Hong Wu
BRD | Director/Board Member | 56 | 23-08-10 |
Shun Yan Zhu
CHM | Chairman | 53 | 20-03-15 |
Rong Shao
BRD | Director/Board Member | 62 | 23-08-10 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 2.59% | 293 M€ | +11.35% | - | |
| 1.56% | 88 M€ | +11.04% | - | |
| 1.56% | 11 M€ | +8.92% | - | |
| 1.42% | 0 M€ | -.--% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-06-03 | 3.37 | +2.74% | 68 915 834 |
| 24-05-31 | 3.28 | -8.64% | 120,438,000 |
| 24-05-30 | 3.59 | +1.13% | 91,951,170 |
| 24-05-29 | 3.55 | +5.03% | 135,124,400 |
| 24-05-28 | 3.38 | +10.10% | 218,269,900 |
Delayed Quote Hong Kong S.E., June 03, 2024 at 04:08 am EDT
More quotes
Alibaba Health Information Technology Limited is specialized in the direct sale of pharmaceuticals. The turnover is divided across the following activities:
- direct sale of pharmaceuticals (85.2%);
- online sale of pharmaceuticals(12.7%);
- direct healthcare services (1.8%);
- online healthcare services and monitoring of pharmaceuticals (0.3%).
The turnover is divided into the revenue sources of product sales (80.8%) and services (19.2%).
The geographical breakdown of the turnover is as follows: mainland China (95.8%) and Hong Kong (4.2%).
Sector
Drug Retailers
Calendar
2024-11-25
- Q2 2025 Earnings Release (Projected)
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
3.038
CNY
Average target price
4.961
CNY
Spread / Average Target
+63.31%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -20.52% | 6.75B | |
| -37.88% | 13.99B | |
| -32.35% | 10.67B | |
| +12.54% | 6.29B | |
| -11.51% | 5.88B | |
| +75.00% | 4.96B | |
| -2.63% | 4.61B | |
| -9.20% | 3.74B | |
| -19.40% | 3.16B | |
| -12.17% | 2.85B |
- Stock Market
- Equities
- 241 Stock
